Paras Biopharmaceuticals Finland Oy Announces Successful Development of Biologically Active Romiplostim (N-Plate® Biosimilar) Production Technology
Oulu, Finland, January 31, 2019 --(PR.com)-- Paras Biopharmaceuticals Finland Oy today announced the achievement of a major milestone – the...








